Click here to get full coverage on PGRN as an emerging regulator of lipid metabolism in neurodegenerative diseases - Nature

PGRN as an emerging regulator of lipid metabolism in neurodegenerative diseases  Nature

PGRN as an emerging regulator of lipid metabolism in neurodegenerative diseases - Nature

Click here to get full coverage on 21Shares Tosses ETFs While Prepping for Spot Crypto Frenzy - The Daily Upside

21Shares Tosses ETFs While Prepping for Spot Crypto Frenzy  The Daily Upside

21Shares Tosses ETFs While Prepping for Spot Crypto Frenzy - The Daily Upside

Click here to get full coverage on Empowered Funds to Liquidate Three ARK 21Shares Crypto-Focused ETFs - MyChesCo

Empowered Funds to Liquidate Three ARK 21Shares Crypto-Focused ETFs  MyChesCo

Empowered Funds to Liquidate Three ARK 21Shares Crypto-Focused ETFs - MyChesCo

Click here to get full coverage on Cathie Wood and Ark launch very un-ARK-like ETF - TheStreet

Cathie Wood and Ark launch very un-ARK-like ETF  TheStreet

Cathie Wood and Ark launch very un-ARK-like ETF - TheStreet

Click here to get full coverage on Arkuda Therapeutics to Present Update on ARKD-104, its First-in-Class Oral Development Candidate for the Treatment of Frontotemporal Dementia and other Neurodegenerative Disorders at the Alzheimer's Association International Conference 2023 - PR Newswire

Arkuda Therapeutics to Present Update on ARKD-104, its First-in-Class Oral Development Candidate for the Treatment of Frontotemporal Dementia and other Neurodegenerative Disorders at the Alzheimer's Association International Conference 2023  PR Newswire

Arkuda Therapeutics to Present Update on ARKD-104, its First-in-Class Oral Development Candidate for the Treatment of Frontotemporal Dementia and other Neurodegenerative Disorders at the Alzheimer's Association International Conference 2023 - PR Newswire

Click here to get full coverage on Arkuda Therapeutics Announces Option and Asset Purchase Agreement - BioSpace

Arkuda Therapeutics Announces Option and Asset Purchase Agreement  BioSpace

Arkuda Therapeutics Announces Option and Asset Purchase Agreement - BioSpace

Click here to get full coverage on Crypto ETFs Surge as Bitcoin Tops $66K - ETF.com

Crypto ETFs Surge as Bitcoin Tops $66K  ETF.com

Crypto ETFs Surge as Bitcoin Tops $66K - ETF.com

Click here to get full coverage on Cathie Wood sells over 300K shares of Jack Dorsey’s Block this week (NYSE:SQ) - Seeking Alpha

Cathie Wood sells over 300K shares of Jack Dorsey’s Block this week (NYSE:SQ)  Seeking Alpha

Cathie Wood sells over 300K shares of Jack Dorsey’s Block this week (NYSE:SQ) - Seeking Alpha

Click here to get full coverage on Proteomic analysis of laser captured tubular tissues reveals complement activation and mitochondrial dysfunction in autoimmune related kidney diseases - Nature

Proteomic analysis of laser captured tubular tissues reveals complement activation and mitochondrial dysfunction in autoimmune related kidney diseases  Nature

Proteomic analysis of laser captured tubular tissues reveals complement activation and mitochondrial dysfunction in autoimmune related kidney diseases - Nature

Click here to get full coverage on Crypto Investment Pioneers 21Shares and ARK Invest Launch Suite of Actively-Managed Digital Asset ETFs - PR Newswire

Crypto Investment Pioneers 21Shares and ARK Invest Launch Suite of Actively-Managed Digital Asset ETFs  PR Newswire

Crypto Investment Pioneers 21Shares and ARK Invest Launch Suite of Actively-Managed Digital Asset ETFs - PR Newswire

Click here to get full coverage on Arkadelphia School District Suspends Three Teachers After DHS Investigation - KATV

Arkadelphia School District Suspends Three Teachers After DHS Investigation  KATV

ARKD

Price Chart

Key Statistics

Top 10 Holdings Distribution

Technicals

About ARKD

Latest News

PGRN as an emerging regulator of lipid metabolism in neurodegenerative diseases - Nature

21Shares Tosses ETFs While Prepping for Spot Crypto Frenzy - The Daily Upside

Empowered Funds to Liquidate Three ARK 21Shares Crypto-Focused ETFs - MyChesCo

Advanced Charts

Fund Information